Peng Du

national key laboratory of advanced biotechnology

H指数:20

被引数:1,124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and Humanization of a Camelid-Derived Neutralizing Nanobody Targeting Botulinum Neurotoxin Type A

骆驼科动物源中和纳米抗体靶向肉毒神经毒素A型的开发与人源化

International Journal of Nanomedicine

IF6.5

2026-09-050

Association of CT-based perirenal structural characteristics with chronic kidney disease risk categories: the additional value of imaging

CT成像显示的肾周结构特征与慢性肾脏病风险等级的关联：影像学的附加价值

Acta Diabetologica

IF2.9

2026-04-150

PRE

Glioma Cell-Derived Apoptotic Extracellular Vesicles Promote Tumorigenesis and Temozolomide Resistance by Delivering LncRNA-XIST

胶质瘤细胞来源的凋亡外泌体通过传递LncRNA-XIST促进肿瘤发生和替莫唑胺耐药性

Journal of Biochemical and Molecular Toxicology

IF2.8

2026-02-160

PRE

Ligilactobacillus murinus alleviates binge-eating behavior by restoring serotonin metabolism

Ligilactobacillus murinus通过恢复5-羟色胺代谢来缓解暴食行为

Food Research International

IF8

2026-02-120

PRE

A clinical risk prediction model for perioperative lower extremity DVT in patients undergoing spinal fracture surgery

脊柱骨折手术患者围手术期下肢DVT的临床风险预测模型

FRONTIERS IN SURGERY

IF1.8

2025-09-180

OAAI

CT-Guided Percutaneous Radioactive 125I Brachytherapy for Locally Advanced Pancreatic Cancer

CT引导下经皮放射性125I近距离放疗治疗局部晚期胰腺癌

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

IF0

2025-09-010

PRE

IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma

IDH1突变产生R-2-hydroxyglutarate (R-2HG) 并诱导mir-182-5p表达以调节神经胶质瘤的细胞周期和肿瘤形成

BIOLOGICAL RESEARCH

IF4.6

2024-05-171

OAAI

Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-209

OAAI

Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer

CELL REPORTS

IF6.9

2022-03-0126

PRE

Bicyclol Alleviates Atherosclerosis by Manipulating Gut Microbiota

SMALL

IF12.1

2022-01-2715

PRE

Intake of Dietary Fiber From Grains and the Risk of Hypertension in Late Midlife Women: Results From the SWAN Study

FRONTIERS IN NUTRITION

IF5.1

2021-09-1611

OAAI

Association of ceramide metabolism with resistance to androgen receptor signalling inhibitors in metastatic prostate cancer

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway

BIOENGINEERED

IF4.2

2021-08-0912

OAAI

Long Noncoding RNA OR7E156P/miR-143/HIF1A Axis Modulates the Malignant Behaviors of Glioma Cell and Tumor Growth in Mice

FRONTIERS IN ONCOLOGY

IF3.3

2021-08-067

OAAI

Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer

无创影像及影像组学解码膀胱癌表型及复发风险的研究进展

FRONTIERS IN ONCOLOGY

IF3.3

2021-07-1516

OAAI

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2021-01-0114

OAAI

ANXA2P2/miR-9/LDHA axis regulates Warburg effect and affects glioblastoma proliferation and apoptosis

CELLULAR SIGNALLING

IF3.7

2020-10-0137

PREAI

M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3

CANCER CELL INTERNATIONAL

IF6

2020-03-2757

OAAI

PRSS contributes to cetuximab resistance in colorectal cancer

SCIENCE ADVANCES

IF12.5

2020-01-0328

OAAI

A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan

JOURNAL OF IMMUNOLOGY RESEARCH

IF3.6

2019-01-137

OAAI

Peng Du

个人简介

教育背景

工作经历

荣誉奖项

研究方向